Peter Gisel-Ekdahl, Envirotainer CEO
June 7, 2022 02:43 PM EDT
Deals
Pharma
Manufacturing

EQT's in­vest­ment arm and Mubadala ink $3B deal for med­ical freight and stor­age com­pa­ny

Tyler Patchen

News Reporter

EQT’s pri­vate eq­ui­ty fund, EQT X, and Mubadala In­vest­ment Com­pa­ny, the in­vest­ment branch of the Unit­ed Arab Emi­rates, are mak­ing a big in­vest­ment in cold …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times